Search

everythinglearnresearchcommunity

for

Search:↓

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

High-frequency ultrasound can effectively visualize and assess hair loss.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

A blood pressure drug, diltiazem, may also help treat influenza.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

New psoriasis treatments are effective but come with side effects and risks.

Antiandrogen therapy helps treat genetic hair loss.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

We need better information on how fathers' exposures affect pregnancy.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Hormonal therapies are safe and effective for treating adult women's acne.